Anthropic (ANTx) Price Target for the End of 2026: Bitrue Research Institute Projection
2026-11-20
Anthropic listed on Nasdaq on November 19, 2026 under the ticker ANT, priced its IPO at $83 and opened at $111.50 before closing the day at $97.17. ANTx is the tokenized version of that stock, offered through xStocks, and Bitrue opened spot trading in it on the same day.
This article explains what ANTx is, what happened on debut day, what Wall Street analysts have published, and three end-of-2026 scenarios built from observed prices. It does not give a single price target, because a stock one day into public trading has no track record to project from. Disclosure: Anthropic is the company that makes Claude, the AI assistant used in preparing this article, and Bitrue also sells ANTx products. It is educational content, not financial advice.
Key Takeaways
ANTx tracks a very new stock. ANT opened 34% above its $83 IPO price and ended its first day 17% above it, after a sharp late retreat.
Analyst targets run from $105 to $155, according to Reuters, but they are initiations from the first days of trading and one is a 24-month target.
Our scenarios for the end of 2026 center on three reference zones: below $83, $83 to about $111, and above $111. They are conditions, not forecasts.
ANTx is not the share. Per Bitrue's press release, holders get price exposure but no shareholder or voting rights, and it is not available to US persons.

What Is ANTx?
ANTx is a tokenized Anthropic stock issued through xStocks. Bitrue's November 19 press release, distributed through Chainwire, says each token is backed 1:1 by Anthropic shares held in custody by Backed Assets (JE) Limited, and that spot trading against USDT opened at 14:30 UTC on November 19.
It also lists ANT/USDT perpetual futures (live since November 17) and ANT3L/ANT3S leveraged tokens (expected November 20) among Bitrue's Anthropic products. That release is marketing, so its claims are the company's own. I could not load Bitrue's listing FAQ on its support site, so I could not confirm further terms.
Do not confuse ANTx with other assets sharing the name. There is the ANT stock itself, the ANTx tokenized stock and several unrelated crypto tokens with "ANT" or "Anthropic" in their names, so confirm the exact product and contract before you trade. For background on how tokenized stocks work, see Bitrue's guides on how to buy tokenized stocks and xStocks listings on Bitrue.
What Happened on Debut Day
Per Investing.com's reporting on November 19:
It was described as the largest stock-market offering on record. The same day, the Nasdaq Composite fell more than 2% to a seven-month low. Valuation figures differ: Investing.com cites about $1.5 trillion at the IPO price, more than $2 trillion at the intraday high and about $1.76 trillion at the close, while another page of its coverage shows a $1.29 trillion market cap at $98.86.
The gap is probably different share counts (basic against fully diluted), which the articles do not say. Markets were closed when I wrote this, so the latest prices I have are the November 19 close and after-hours figures. Check a live quote.
The Financial Picture
The Bitrue Research Institute's October 27 piece, written after the S-1 filing, summarized the company's reported numbers: revenue of about $4.6 billion in 2025 and about $16.3 billion in the first half of 2026, a first-half operating loss of $693 million and large compute commitments.
Investing.com's debut-day coverage cites trailing revenue of $35.3 billion, a 22% gross margin, continued unprofitability and aggregate compute commitments of $900.9 billion, of which $70.7 billion falls due in the next 12 months. The two sources use different periods and come from different publishers, so I did not reconcile them. Reported demand was about $400 billion from institutions and nearly $100 billion from retail.
What Analysts Say
Reuters, via Investing.com, listed initiations on November 19:
William Blair also initiated with an Outperform rating, with no target in the snippet I read. Melius's $155 implies nearly 87% upside from the IPO price. Note that these are early initiations, Reuters does not say whether any of the firms were IPO underwriters, and targets are not guarantees.
A Bitrue Research Institute article from October 27 also quoted some commentators expecting a drop of 40% or more after a mega-IPO, so views are far from unanimous.
Bitrue Research Institute Scenarios for End of 2026
Bitrue Research Institute describes itself as the exchange's in-house analysis division and often frames its work as scenarios. Its October piece used three valuation anchors, about $965 billion (the last private round), $1.5 trillion and $2 trillion or more, and framed them as a scenario tool, not a price target. Those anchors map neatly onto share prices once the IPO is known. The IPO price of $83 at about 1.5trillionimpliesroughly18.1billionshares,thesamecountimpliedbytheclose(1.76 trillion at $97.17). Using that count, my arithmetic is below. It ignores future dilution and uses the diluted count only, so treat it as approximate.
These carry no probabilities, and none of the sources provides one. A small revenue slowdown can matter a lot at this valuation: the Institute's October estimate had quarterly growth falling from over 140% in Q2 to about 45% in Q3. What would change the picture: the first public earnings report, lock-up expirations, competition from cheaper models, and the compute commitments. ANTx is designed to track ANT, but its price will not be identical to the stock's.
How ANTx Can Differ From the Stock
Trading hours. Tokenized stocks can trade outside Nasdaq hours, so the token can move when the stock is closed, and price gaps can appear at the open.
Premium or discount. Token prices can drift from the share price, especially in thin or volatile conditions.
Rights. Per Bitrue's release, no shareholder or voting rights.
Access. It is not available in the US or to US persons, and other restrictions apply.
Derivatives. The futures and leveraged tokens carry high risk and can lose their full value quickly.
Using Bitrue AI Around a New Listing
New listings are volatile, which is when entries, exits and position size matter most. Bitrue AI is an explainable AI trading tool that reviews order books, volume and volatility, then proposes strategies with entry, exit, take-profit and stop-loss levels, backtesting and a risk rating, in Stable, Growth and Aggressive styles.

I cannot run Bitrue AI or read its outputs, so this article contains no Bitrue AI analysis of ANTx, and I have not invented one. Bitrue's public Bitrue AI page does not list supported assets, so check the Bitrue AI strategy page or the app for ANTx coverage.

Source: Bitrue AI Dashboard
Bitrue AI does not guarantee profits, and a stop-loss can fill below its trigger in a fast market. See our guides on how Bitrue AI works, how to use Bitrue AI and whether Bitrue AI guarantees profits. If you want to try Bitrue, you can register for an account.
For the Institute's pre-IPO framing, read Anthropic IPO stock price forecast, which is Bitrue's own commentary and includes promotion for Bitrue products. See also the best platforms to buy tokenized stocks in 2026.
Is ANTx a Good Investment?
That depends on your risk tolerance, and the evidence cuts both ways. In its favor: very fast revenue growth, record demand, and several Buy-rated initiations. Against it: a first-day gain that faded into the close and after-hours, a valuation near $1.5 trillion to $1.8 trillion, large compute commitments, ongoing losses, a market sell-off on debut day and a tokenized wrapper with no shareholder rights. Only use money you can afford to lose.
Key Risks
Valuation risk. A high valuation leaves little room for slower growth.
New-listing volatility. The debut-day range was wide, and early trading history is short.
Lock-ups and supply. Later share releases can pressure price, though I did not read the lock-up terms.
Tokenization risk. Custody, issuer, premium or discount and regional restrictions apply to ANTx.
Leverage. Futures and leveraged tokens can lose value fast.
Source limits. Analyst targets come from early initiations, the Bitrue ANTx FAQ did not load and some valuation figures conflict.
Conflicts of interest. Bitrue sells ANTx products, and Anthropic made the AI assistant used here.
Conclusion
ANTx gives non-US users price exposure to Anthropic's stock, which listed at $83, opened at $111.50 and closed its first day at $97.17. Analyst targets run from $105 to $155, but they are early and not guarantees.
Our scenarios give conditions, from below $83 to above $111, instead of a single number. Check the live price, read the product terms, keep position sizes small and treat leveraged products with extra caution. This is not financial advice.
FAQ
What is the ANTx price target for the end of 2026?
There is no reliable single target. Analysts' published targets range from $105 to $155, and our scenarios use reference zones below $83, from $83 to about $111, and above $111.
What is ANTx?
A tokenized Anthropic stock issued through xStocks. Bitrue says each token is backed 1:1 by shares held by Backed Assets (JE) Limited, with price exposure but no shareholder or voting rights.
Is ANTx a good investment?
It is speculative. The stock has strong growth and analyst support but a high valuation, a short trading history and tokenization risks.
Can US users trade ANTx?
No. Bitrue's release says ANTx is not available in the US or to US persons, and other regional limits apply.
Does Bitrue AI guarantee profits?
No. Bitrue AI explains its suggestions and lets you set risk controls, but it does not guarantee profits.
Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.
Disclaimer: The content of this article does not constitute financial or investment advice.



